6533b7d7fe1ef96bd1267b41

RESEARCH PRODUCT

Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study.

Frank RoeschChandrasekhar BalSanjana BallalEuy Sung MoonMadhav Prasad YadavBharadwaj Srinivas ManguMadhavi TripathiRanjit Kumar SahooSamta KumariShipra AgarwalAvinash Tupalli

subject

AdultMaleEndocrinology Diabetes and MetabolismSalvage treatmentIndiaPilot ProjectsEndocrinologyFibroblast activation protein alphaRefractoryPositron Emission Tomography Computed TomographyMedicineHumansProspective StudiesThyroid NeoplasmsPrecision MedicineThyroid cancerProtein Kinase InhibitorsAgedbusiness.industryPhenylurea CompoundsMiddle AgedSorafenibmedicine.diseaseCancer researchQuinolinesFemalebusiness

description

Background: This exploratory study was to assess clinical and safety data with a novel fibroblast activation protein inhibitor-based targeted theranostics as a salvage treatment option in radioiodi...

10.1089/thy.2021.0412https://pubmed.ncbi.nlm.nih.gov/34641705